6-150389522-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_203395.3(IYD):c.349G>A(p.Asp117Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000122 in 1,613,948 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_203395.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IYD | NM_203395.3 | c.349G>A | p.Asp117Asn | missense_variant | 2/5 | ENST00000344419.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IYD | ENST00000344419.8 | c.349G>A | p.Asp117Asn | missense_variant | 2/5 | 1 | NM_203395.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000237 AC: 36AN: 152206Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000115 AC: 29AN: 251416Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135874
GnomAD4 exome AF: 0.000110 AC: 161AN: 1461742Hom.: 0 Cov.: 31 AF XY: 0.000114 AC XY: 83AN XY: 727180
GnomAD4 genome AF: 0.000237 AC: 36AN: 152206Hom.: 0 Cov.: 32 AF XY: 0.000229 AC XY: 17AN XY: 74348
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 15, 2021 | The c.349G>A (p.D117N) alteration is located in exon 2 (coding exon 2) of the IYD gene. This alteration results from a G to A substitution at nucleotide position 349, causing the aspartic acid (D) at amino acid position 117 to be replaced by an asparagine (N). The p.D117N alteration is predicted to be tolerated by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at